As one of the world’s largest medical device companies, Medtronic has undergone several transactions this year including one of the year’s biggest, paying $42.9 billion for Covidien in June. The transaction is expected to be complete by the end of this year or the beginning of next year.
The deal has drawn scrutiny from President Obama and lawmakers because Medtronic plans to take its headquarters to overseas to Ireland, where Covidien is based. The move will free up $10 billion for the company to fund research and development.
More articles on orthopedic devices:
Blue Belt Technologies adds Professor David Barrett to scientific advisory board
K2M stock hits crucial point—5 things to know
Amedica appoints Anan Natarajan vice president of business development
